🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

308 results for “Disc Medicine” Clear

  1. Sovaldi 400 mg film-coated tablets

    Disc Medicine

    Healthy volunteers

    approved small molecule active

    1 trial

  2. Sugammadex hameln 100 mg/ml oplossing voor injectie, Naloxon HCl Accord 0,4 mg/ml, oplossing voor injectie / infusie in een voorgevulde spuit, ANEXATE 0,5 mg/5 ml, solution injectable (I.V.), REMIMAZOLAM , Sufentanil Viatris 5 microgram/ml oplossing voor injectie, Esmeron 10 mg/ml, oplossing voor injectie

    Disc Medicine

    General anesthesia

    approved small molecule active

    1 trial

  3. TAGRISSO 80 mg film-coated tablets

    Disc Medicine

    EGFR mutated locally advanced or metastatic non-small cell lung cancer

    approved small molecule active

    1 trial

  4. TAGRISSO 80 mg film-coated tablets

    Disc Medicine

    EGFR mutated locally advanced or metastatic non-small cell lung cancer

    approved small molecule active

    1 trial

  5. TAMOXIFEN

    Disc Medicine

    Breast cancer

    approved small molecule active

    1 trial

  6. TICAGRELOR

    Disc Medicine

    Acute coronary syndrome

    approved small molecule active

    1 trial

  7. TILMANOCEPT, TILMANOCEPT, GALLIUM (68GA) CHLORIDE, TECHNETIUM (99MTC)

    Disc Medicine

    Oral cancer

    approved small molecule active

    1 trial

  8. Talzenna 1 mg hard capsules

    Disc Medicine

    Breast cancer

    approved small molecule active

    1 trial

  9. Tetanusvaccin, suspensie voor injectie 40 IE

    Disc Medicine

    Systemic sclerosis, Systemic lupus erythematosus, Rheumatoid arthritis

    approved small molecule active

    1 trial

  10. Ultomiris 300 mg/30 mL concentrate for solution for infusion

    Disc Medicine

    Paroxysmal nocturnal hemoglobinuria (PNH)

    approved small molecule active

    1 trial

  11. VENLAFAXINE

    Disc Medicine

    Major Depressive Disorder

    approved small molecule active

    1 trial

  12. Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geïnactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    healthy individuals

    approved small molecule active

    1 trial

  13. Vitamine E-400 complex, Microgynon 30, 0,15 mg/0,03 mg omhulde tabletten

    Disc Medicine

    Migraine

    approved small molecule active

    1 trial

  14. XELJANZ 11 mg prolonged-release tablets

    Disc Medicine

    Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria

    approved small molecule active

    1 trial

  15. Xolair 150 mg solution for injection in pre-filled syringe, Physiological saline

    Disc Medicine

    Carotid artery stenosis

    approved small molecule active

    1 trial

  16. Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZ 300 mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  17. [68Ga]FAPI-46

    Disc Medicine

    post-acute sequelae of COVID-19

    approved small molecule active

    1 trial

  18. [68Ga]FAPI-46

    Disc Medicine

    Non-resolving ARDS

    approved small molecule active

    1 trial

  19. [68Ga]FAPI-46

    Disc Medicine

    Peyronie's Disease

    approved small molecule active

    1 trial

  20. Adiposity and Iron Requirements in Pregnancy (ADIPREG)

    Disc Medicine

    Iron Deficiency Anemia of Pregnancy

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources